Can a pill beat dandruff? oral antifungal takes on stubborn scalp condition

NCT ID NCT07734441

First seen Jul 29, 2026 · Last updated Jul 30, 2026 · Updated 1 time

Summary

This trial tests whether oral itraconazole, taken as a pulse therapy over six months, works better than a standard ketoconazole shampoo for moderate to severe scalp seborrheic dermatitis. Eighty participants aged 14 to 70 will be randomly assigned to one of the two treatments. Researchers will measure changes in severity scores, relapse rates, and patient satisfaction to see if the oral option offers lasting relief.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
oral itraconazole (pulse therapy) and topical 2% ketoconazole shampoo
What this could lead to
If itraconazole proves more effective, it could offer a new oral treatment option for stubborn scalp seborrheic dermatitis with fewer relapses.
What could go wrong
This is a small early-phase trial, so results may not apply broadly. Itraconazole carries risks of liver toxicity and drug interactions, and oral antifungals are not first-line for this condition.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SEBORRHEIC DERMATITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • CMH Bahawalpur

    RECRUITING

    Chak Four Hundred Fifty-four, Punjab Province, 63100, Pakistan

More trials for these conditions

Other studies related to the condition(s) this trial covers.